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Abstract 
Recently, we have reported the cloning of the rat 5-HT,, receptor cDNA. This receptor is particularly interesting since it may be involved in diseases 
such as migraine. Here, we describe the isolation of a human 5-HT,, receptor clone from a cDNA library derived from SH-SYSY cells. Although 
the receptor sequence was only 80% homologous to the rat sequence, the exon-intron distribution was conserved between the two species. In the 
human body, the receptor mRNA was detected in most peripheral organs. Only low expression levels were found in the brain. After expression in 
HEK 293 cells, activation of the receptor stimulated the production of phosphatidylinositol. The pharmacology of this functional response correlated 
well with that of the rodent receptor. 
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1. Introduction 
Molecular cloning has revealed the existence of more 
than thirteen serotonin receptor types belonging to vari- 
ous subgroups [l]. With the exception of the SHT, re- 
ceptors which are ligand-gated ion channels, all known 
serotonin receptors belong to the family of seven-helix 
receptors which couple to GTP binding proteins. The 
three receptor subtypes which are thought to stimulate 
phosphatidylinositol turnover [2,3] are called 5-HT,,, 
5-HTzB, and 5-HTZc. The latter was called 5-HTlc in the 
older literature [4]. In addition to their similar second 
messenger coupling, these three receptors can be distin- 
guished from other serotonin receptors due to their sim- 
ilar pharmacology, high sequence homology, and, in the 
mouse genome, highly conserved intron-exon distribu- 
tion [5]. Central effects of the 5-HT,, receptors include 
an involvement in the serotonin induced wet-dog shake 
behavior [6] and behavioral excitation [7]. In the periph- 
ery, activation of this receptor causes vasoconstriction 
and platelet aggregation [S], and increased body temper- 
ature [9]. The 5-HTZc receptor is expressed throughout 
the brain [lO,l l] and on the epithelial cell layer of the 
choroid plexus [ 121. This receptor type has been reported 
to increase grooming, penile erection, oxytocin secretion 
[ 131, and transferrin levels in the choroid plexus [14]. 
Serotonin 5-HT,, receptors were first functionally 
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characterized in the rat stomach fundus where they trig- 
ger muscle contraction [15]. The human stomach does 
not contain a contractile tissue similar to the rat stomach 
fundus. Therefore, no function can unequivocally be as- 
cribed to this receptor type in humans. There are, how- 
ever, several 5-HT, receptor functions in which this re- 
ceptor type may be involved. Usually it is not possible 
to distinguish between 5-HT,, and 5-HT,, receptor ac- 
tion based on the pharmacology reported in the litera- 
ture. Therefore, several functions which were thought to 
be 5-HTZc receptor mediated may involve the 5-HT,, 
receptor. This includes the role of serotonin receptors in 
alcohol intake [ 161, in the reduction of aggressive behav- 
ior [ 171 or in neuroendocrine ffects [18]. It is of particu- 
lar interest that the involvement of serotonin receptors 
in the onset of migraine attacks, which has been specu- 
lated to be 5-HT,, receptor mediated [19], may equally 
well be caused by 5-HT,, receptors [20]. The cloning and 
characterization of the human receptor type described 
here therefore provides a tool to study the involvement 
of the receptor in these physiological and pathological 
processes. 
2. Materials and methods 
2.1. Oligonucleotides 
ON 14, rat sequence; ON 5-13, human sequence. 
ON 1: AGGCTATATGGC CCCTCCCACT 
ON 2: GAAATTAAC CATACCACTGTAATC TTG 
ON 3: GCATCGCCATCC CAG TCC CTAT 
ON 4: AAAAGGGGCACCACATAAGC 
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ON 5: ACGTTC TCTTTTCAACCG CA 
ON 6: CCGGTGACGAGCAAGGTGTT 
ON I: TTATCACCATGAGTATCAGA 
ON 8: GCTGTTTCACTGGAGAAGAA 
ON 9: TGC AGTTTATTT CCC TGTTC 
ON 10: GAAGCT GCAGTATGC TAC TAAT 
ON 11: GAAATAACC AGG CAG GAC AT 
ON12: ACC AGG CAGGACATAGAACA 
ON13: CAAATC CAGGCCAAT CAATA 
2.2. Cloning, sequencing and sequence analysis 
Two sets of primers were synthesized coding for transmembrane 
domain III/IV (ON 1 and 2) and IVM (ON 3 and 4) of the rat 5-HT,, 
sequence. PCR reactions with primer pairs ON 1 and 2 or ON 3 and 
4, respectively, were performed using 1 pg of HeLa cell DNA as a 
template. The reaction was performed for 32 cycles in a total volume 
of 50 ~1. Both PCR products were reamplified in a second PCR using 
2 ,~l of the first PCR with the same primer pairs for another 32 cycles. 
Products were isolated by agarose gel electrophoresis and sequenced 
directly using the Hot tub DNA sequencing kit (Amersham). From the 
resulting human sequence specific oligonucleotides ON 5 and 6 were 
designed for the cDNA library screening. Poly A+ RNA was isolated 
from SH-SYSY cells and a cDNA library was prepared in a modified 
bluescript vector as described previously [2]. The library was trans- 
formed into E. coli MC 1061 by electroporation (Gene Pulser, BioRad). 
It contained 2 x lo7 independent transformants with an average insert 
size of 2 kb. Each of 25 pools with 5 x 10“ clones were grown overnight 
and plasmid DNA was isolated. Of these DNAs, 0.5 pg were linearized 
and PCR was performed using the human primers ON 5 and 6 as 
described above. Four pools gave rise to the expected PCR product. 
One of them was transformed into E. coli DH5a, plated on agar and 
screened by standard filter hybridizations [21] using a PCR ssDNA 
probe [22]. DNA sequencing was performed with the T7 sequencing kit 
from Pharmacia. The DNASIS and PROSIS programs (Hitachi) were 
used for the sequence analysis. 
2.3. Determination of exon-intron boundaries 
The location of introns within the 5-HT,, receptor gene was deter- 
mined using inverse PCR [23] and direct sequencing of the PCR prod- 
ucts. To determine the exon-intron boundaries within the coding re- 
gion, 5 pg of HeLa cell DNA was digested with R.saI. After circulariza- 
tion of 200 ne DNA with T4 DNA-ligase in a final volume of 100 ul, 
30 cycles of PCR were performed with40 ng of this DNA and 10 pm01 
each of the primers ON 7 and 8 or ON 11 and 5. Of these PCRs 2 ~1 
were further amplified using the nested primer pairs ON 9 and 10 or 
ON 12 and 13 under identical conditions. PCR products were isolated 
by agarose gel electrophoresis and sequenced irectly as described. 
2.4. Distribution of receptor expression i  human RNA’s 
The receptor RNA was identified by RT-PCR. RNAs from human 
tissues were obtained from Clontech. For the RT-PCR 1 pg of each 
RNA was reverse transcribed in a final volume of 20 ~1 using M-MLV 
reverse transcriptase (BRL) in PCR-Buffer (Boehringer) according to 
supplier’s instructions. The PCR contained 2 ,nCi [a-“P]dCTP and 
10 pmol each of the primers ON 5 and 6 in a final volume of 50 ~1. The 
“P-labeled PCR-products were separated on 4% agarose gels (NuSieve, 
FML). The gels were dried and exposed to X-ray films. 
2.5. Functional characterization f the receptor 
The human 5-HT,, receptor cDNA was subcloned into the San 
restriction site of the mammalian expression vector pXMD1 [24]. HEK 
293 (Human Embryonic Kidney) cells were grown in MEM (Earl’s 
salts, r,-glutamine) supplemented with 10% fetal calf serum. For trans- 
fection, the cells were plated at 1.5 x lo6 cells per 10 cm plate and used 
for transfection 24 h later. Plasmid DNA (6 pg per 10 cm plate) was 
transfected with the CaPO, method as described [25]. 
For the measurement of the [‘Hlinositol phosphate formation cells 
were split into 12 wells of a 24-well plate 24 h after transfection and 
labeled to equilibrium with [3H]inositol (3 @/ml) for an additional 
24 h in growth medium. Then, two min after applying Li’ (20 mM) in 
HBS-buffer (130 mM NaCl, 900 PM NaH,PO,, 800 PM MgSO,, 
5.4 mM KCl, 1.8 mM CaCl,, 25 mM glucose in 20 mM HEPES pH 7.4) 
cells were stimulated by the addition of the agonist. Antagonists were 
added 5 min prior to 10.’ M 5-HT. The measurement of total [‘Hlinos- 
itol phosphate formation was performed as described [26]. 
3. Results 
3.1. Isolation of a human 5-HT,, receptor cDNA clone 
To obtain some sequence information on the human 
5-HTzB receptor we amplified and sequenced Hela cell 
DNA from individual exons of the 5-HT,, receptor gene. 
Assumptions about the exon-intron distribution were 
based on that in the mouse genome [5]. For the cloning 
of the human 5-HT,, receptor cDNA we then searched 
for human cell lines expressing this receptor. Using RT- 
PCR with primers derived from the human sequence and 
direct sequencing of the PCR products, we found rela- 
tively high levels of 5-HTz, receptor mRNA in the 
human neuroblastoma cell line SH-SYSY (data not 
shown). We then prepared a cDNA library from these 
cells and isolated a 5-HT,, receptor cDNA clone from 
this library. The sequence contained an open reading 
frame encoding a protein of 483 amino acids (Fig. 1A). 
The hydrophobicity plot displayed seven hydrophobic, 
putatively membrane-spanning domains (data not 
shown). The protein contained five consensus equences 
for N-linked glycosylation [27], one of them located 
within the putatively extracellular N-terminal domain 
and two in the last and second-last extracellular loop 
(Fig. 1A). A potential site for palmitoylation was present 
in the carboxyterminal part of the molecule (Fig. 1A). 
Depalmitoylation at an analogous site of the /I,-adrener- 
gic receptor has resulted in receptor uncoupling [28,29]. 
Although the sequence contained recognition motifs for 
various protein kinases [30], including CAMP- and 
cGMP-dependent protein kinases, casein kinase II and 
S6 kinase, there was no consensus equence for phospho- 
rylation by protein kinase C. Of particular interest may 
be the recognition sequences for CAMP-dependent pro- 
tein kinases in the third intracellular loop and the car- 
boxy-terminus. 
3.2. IdentiJication of exon-intron boundaries in the 
human 5-HTzB receptor gene 
The location of introns and the sequences of the exon- 
intron boundaries in the human 5-HT,, receptor gene 
were determined using inverse PCR and direct sequenc- 
ing of the PCR products (Fig. 1A and B). Two introns 
were found between nucleotides 4071408 and 6081609. In 
these same locations introns are present in the genes for 
all three mouse 5-HT, receptor subtypes [5]. Further 
PCR experiments with HeLa DNA confirmed the ab- 
sence of additional introns within the coding region (data 
not shown). 
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A 
1 1 ACT MC CAT GCT GAC CAC TGl 1CG GAA CGG GAt TGA ATC ACA GM AM WC CAA ATG CC1 CTC TCT TAC AGA GTG TCT G4A Cl, 
1 Uet Ala Lcu Ser lyr ArG Val Ser 611~ LCU 
l 
86 CAA AGC ACA Att CCT GAG UC ATT TTG CAG AGC ACC 111 OTT CAC Glt ATE 1Ct TCT MC TGG 1’3 W TTA CAG ACA GA4 t:. ATA 
1, G,,, Ger thr Ilc Pro Glu His lie Lar Gin =Ser Thr Phe Val His Vd llc SW SW As" ttp SW Gty Lsu 61n Thr Glu Scr ile 
173 CW GAG GM A7G AAA CAG Al, Gll G4G GA. CAG GGA Ml AM CTG UC TGG @ZA GCT CT1 CTG Al1 CTC ATG GTG ATA AlA CCC ACA 
40 Pm Olu 0111 "et Lys Gtn Its Vat Glu GLu GLn Gly &an Lys La His trp Ala Ala LUJ Lw Xlr Lcu Wet Val Ile ILc Pro Thr 
260 Aft GGl GGA AAt ICC CTT Gtl ATT CTG CC1 Gll TCA CTG GAG MC MC CTG CAG TAT GCT ACT MT TAC TTT CTA ATG TCC TTG GCG 
69 Ile Gly Cly As" lhr Leu Val fle Leu Ale Vd Scr Leu Glu Lys Lys Leu Gin Tyr Ala Thr Am lyr Phc la, Yet SOP Lcu ALa I 
y,,’ 6,~ CC, CA, ,,G CT0 CT, GM it-2 ,I, GtG Att CCA ATT GCC CTC TTG AU ATA ATT0 111 GAG CC1 ATG TOO CCC CTC CCA CT1 Wt 
98 "a, Als Asp Lcu Lcu Val Gty Lcu Phc V., "et Pro Ile Ale Lw Lcu lhr Its "et Phr Glu Ale "et trp Pro Le" Pro Lcu Vat 
434 STA TGT CC1 GCC TGG TTA TTT Clt GAC Gtt CTC 111 TCA ACC GCA TCC ATC ATG CAT CTC TGT GCC ATT TCA GTG GA1 CGT tAC ATA 
127 Leu Cys Pro Ala Trp Leu Pha Leu Asp Vat Lw Phc SW Thr Ala Ser Ilc Ret His Lw Cys Ala Itc SW Val Asp ArG lyr Ile 
II 
5.2, GCC AK AM AAG CCA ATC CA0 GCC Ml CAA TAT MC TCA CGG GCT ACA GCA TTC ATC MG At, ACA GTG GTG TOG TTA ATT TCA ATA 
156 Ala Il.? Lys Lys Pro ILa Gin Ala As" Gin lyr Asn SW Arg Ala Thr Ala Pha IIC Lr ILC Thr Vd Val Trp Lw Ile Scr llc 
I 
608 50~ Alt GCC Alt CCA GTC CC1 All AM GGG ATA GAG ACT OIT OTC WC MC CCA MC Ml ATC ACT 161 GtG Cl0 ACA AA0 WC. CGt 
185 G,y ile Ale Ike Pro Vat Pro ft.? Lys Gly Ile Glu Thr Asp VP1 AspAs" Pro Am Aan Ike thr Cys Val Le" lhr Lyr Glu ArG 
695 Ttl GGC GAT TtC ATG CTC Tll GGC tCA ClG GCl G!X TTC tlC AU CCl CTT GCA ATT Al0 All WC ICC TAC TTT CIC ACT Att UT 
214 Phc Gly Asp Ra "et La, Pha Sly Ecr Le" Ala At& PhC PhC Thr Pro Le" ALa Ilrllct IL& Vat Thr lyr &'he Lw thr lie His 
782 GC, ,,A CAG MG AAG GCT TAC l,A GtC AAA MC MO CCA CC1 CAA CGC CtA ACA TGG TTG ACT GTG tCt ACA Gtl t,C CM AGG GA1 
243 Ala Le" Gin Lys Lys Ala Tyr Lnr Val Lys As" LyS Pro Pro Gin A;!, Le" thr trp Lw Thr Val Scr Thr Vat Phc Gln ArS Asp 
t 
869 GAA ACA CC1 tGC t:G TCA CC0 GM MC GTC CCA ATE CTG GA1 GGT TCT CGA MC CAG MC GCT CTG CCC MC TCA GGT G41 GM ACA 
272 GLu Thr Pro Cys Ser SW Pro Glu Lys Val Ala let LaU Asp Gly Ser ArG Lp Asp LyS Ala Leu Pro Am SW Gly Asp Glu Thr 
956 Ctt AtG CGA AGA ACA XC ACA All GGG MA MG 1’3 GTG CA6 ACC All TCC MC GAA CA0 AGA CCC TCA AA0 m Cl1 GGG All GT$ 
301 Le" Net ArG ArS Thr SW lhr Ilc Gly Lys Lys SW VBt Gln l? Ile Ser Ann GlU Gin ArG Ala Ser Lys V$ Lw Gly lie VPL 
,043 Tll 1,C CtC it, TTG CT1 ATG KG lG1 CCC l,C T,T Al, AU MT AtA ACT TTA GTT TTA lG1 GAt TCC TOT MC CM ACl ACT CTC 
330 Phe Phe LCU Pha Lw Lau Wet lrp Cys Pro phe Pha IlC The AM Ilc lhr La" Vel Ls" Cy‘ Asp Jar C,‘, As” Gin lhr lhr Leu 
* 
,130 CAA A,G UC CTG GAG ATA TTT GtG tGG AtA GGC TAT OTT KC TCA GGA GTG MT CC1 TTG GTC TAC ACC CTC TX Mt MG ACA TTT 
359 GL,, "et Lw Leu Glu Ile Phc Vel Trp Ila Gly lyr Val Ser Sar Gly Vat Asn Pro Lw VP1 tyr Thr Leu Phe Am Lys Thr Pha 
I . 
1217 CGG CAT GCA ltl GGC CGA TAT AlC ACC 1GC Ml TAC COG GCC ACA MC TCA OTA AM ACT CTC AGA AM CGC ICC AGt AAG ATC TIC 
388 ArS Asp Ala Phe Gly ArG Tyr Ike lhr Cys Asn Tyr ArS Ala lhr Lys Ser Val Lys lhr Leu ArS Lys ArS Ser Scr Lyr Ilc tyr 
1304 TTC CCC Ml CCA AtG GCA GAG MC tCt MG TTT TTC MO AAA UT GW ATT CGA Ml GGG ATT MC CC, GCC ATG TAC UC AGT L!CA 
417 Phc ArG Asn Pro Wet Ala Glu Asn Ser Lys Phc Pha Lys Lys His Gty Ile Am Asn Gly $1~ Am Pro Ala hot Tyr Gin Scr Pro 
1391 A,G AGG CtC CGA AGT TCA CC AIt CAG tCT ,CA TU ATC ATT CtA CtA G4T ACG CT1 CTC Clt ACT GAA Ml GAA GGT &AC AAA ACT 
446 Wet ArS Lw ArS See SW Thr Ilc Gin Ser Scr Ser tic flc Lcu Lw Asp Thr Lw Leu Leu Thr 61%~ Asn GLu Cty Asp Lys lhr 
1478 GAA GAG CA4 Gt, AGt TAT GTA TAG CAG MC TGG CAC TTG TCA lCA MC ATA ATG ATG AGl MC A,G ATG MT GAG ATG TM AtG TGC 
473 Glu Glu Gln Val Ser lyr Vrl *** 
1565 CCA GAA TAT Atl ATA TM AU ATT tlA 1Gt CAT ATA TCA Ml CAT CtC 111 MC CTA AGA TGT MG TAT TM GAA TAT CTA At, TTC 
1652 CTA All TGG ACA AGA TTA 1lC CAT OAG GAA Ml MT 111 ATA TAG CT1 CAA ATG AAA ACA ATC CAG CAC TCT GGT TM ATT TTA AGG 
1739 TAT TCG MT GAA ATA MO TCA AA, CAA TM All TCA CCC 111 AAA MA AM AM AM AAA AA4 
B 
407 
. . . . won . . . . . . . . . ATA ATG TTT Gptaa~tamcactttattt . . . . . . ..intron . . . . . . cttptttttctncntcag~ GCX ATG TGG... 
a08 
. . ..exon. . . . . . . . .ATT TCA ATA Ggt~~oas~tgccagagtgt.. ..intron. . . . . . 
Fig. 1. (A) Nucleic acid and deduced amino acid sequence of the human 5-HT,, cDNA and (B) sequences of the exon-intron boundaries. Underlined 
are the putative membrane spanning regions. Consensus equences for N-linked glycosylation are marked by an asterisk, a bar marks the Cys which 
is possibly attaching the C-terminal region to the membrane via a palmitoyl anchor. Several recognition motifs for protein kinases are indicated (o 
CAMP-dependent protein kinase, CI cGMP-dependent protein kinase, + casein kinase II, 4 S6 kinase). Splice sites are marked by an arrow. Nucleotides 
indicated by capital letters are located in exons, those in lower case letters in introns. The human 5-HT, receptor sequence has been deposited at 
the EMBL data library with the accession umber X77307. 
3.3. Protein sequence comparisons 
The human 5-HT,, aminoacid sequence displayed 79 
and 82% overall sequence identity to the rat and mouse 
5-HTZB receptors, respectively 12,311, 58% homology to 
the human 5-HT2A [32] and 51% to the human 5-HTZc 
receptor [32]. The homology within the membrane span- 
ning regions was 91.5, 92, 71, and 73% for the rat and 
mouse SHT,,, the human 5-HT,, or SHT,, receptors, 
respectively. The usual amino acids are conserved in this 
member of the family of G-protein coupled receptors. An 
alignment of the hman, rat and mouse 5-HT,,, the 
human 5-HTM, and the human 5-HTX receptor se- 
quences are depicted in Fig. 2. 
3.4. Distribution of receptor RNA 
Using RT-PCR with RNAs isolated from various 
human organs, we have analyzed the distribution of re- 
ceptor expression (Fig. 3). Although this kind of analysis 
is, without using internal standards, only se~quantita- 
tive, we found relatively high levels of expression in most 
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Fig. 2. Alignment of the human, rat and mouse SHT,, [2,31] and the human MIT,, and 5-HT,, [32] receptor sequences. Bars represent the putative 
membrane spanning regions. Amino acid identities are illustrated by asterisks. 
peripheral tissues. Strongest signals were found with kid- 
ney, heart and intestine cDNAs. Only very low expres- 
sion levels were seen in the brain and in blood. 
3.5. Functional c~urueterj~ation of the clean ..S-IZTT~~ 
receptor 
After transient expression of the receptor in HEK 293 
cells, serotonin application to the cells stimulated the 
hydrolysis of phosphatidylinositol. The pK, for sero- 
tonin in this assay was 8.04. Other agonists, DO1 and 
MeOT, stimulated the second messenger system to simi- 
lar levels. Their potencies were 7.95 and 7.63, respec- 
tively (Fig. 4A). The concentrations of the antagonists 
yohimbine, mianserin, pizotifen, and spiperone required 
for 50% inhibition of the stimulatory effect of serotonin 
were determined (Fig. 4B). Apparent Ki values were then 
432 
Distribution of the human 5-HT2B-receptor mRNA 
Fig. 3. Distribution of the 5-HT,, receptor gene expression. After re- 
verse transcription of the RNAs 32 cycles of PCR were performed. PCR 
products were separated by gel electrophoresis. The size of the PCR 
products are indicated in base pairs. 
estimated from these IC,, values, adapting the Cheng- 
Pr~soff equation [33], Ki = IC,d(l + [5-HT]/EC,,), 
where [5-HT] is the serotonin concentration used (= lo-’ 
M) and EC,, the concentration of serotonin producing 
half-maximal stimulation (= 9 x 10m9 M). For yohim- 
bine, mianserin, pizotifen, and spiperone the ply, values 
were 7.61, 7.23, 8.18, and < 5, respectively. 
4. Discussion 
We have isolated a cDNA clone for the human 5-HT,, 
receptor from SH-SYSY cells and determined the exon- 
intron distribution of the human gene. Although the 
overall sequence homology between the rodent and 
human receptors is relatively low (about 80%), it is sig- 
nificantly higher within the putative membrane-spanning 
regions (above 90%). Based on the homology and the 
pharmacological characteristics of the receptors, they are 
clearly species homologs of one another. The human 
receptor contains an N-linked glycosylation signal in its 
N-terminal extracellular domain. This signal is neither 
found in the rat nor in the mouse receptor. This observa- 
tion may be of interest but it cannot yet be interpreted 
since functional importance of these glycosylation sites 
which occur in almost all G-protein coupled receptors 
could not be demonstrated [34]. 
The gene of the 5-HT,, receptor contains at least two 
introns in positions where introns were also found in the 
mouse 5-HT,,, .5-HT,,, and 5-HTZc receptor genes [5]. 
This emphasizes the close relationship between these re- 
ceptors which in evolution have obviously developed 
from a common ancestor. 
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Fig. 4. Stimulation of phosphatidylinositol hydrolysis by the human 
S-HT2a receptor expressed in HEK 293 cells. (A) HEK 293 cells tran- 
siently expressing the receptor were stimulated with the indicated con- 
centration of the agonists 5-HT, DOI, and MeOT. The accumulation 
of inositol phosphate was determined. Shown are the means of three 
independent determinations in a representative experiment. (B) Inhibi- 
tion of the stimulation triggered with lo-’ M serotonin by increasing 
concentrations of various antagonists. 
In humans the receptor is expressed in most peripheral 
organs. Only low expression levels are found in brain and 
blood. In a previous study where we analyzed the distri- 
bution of the rat 5-HT,, receptor, we found by far the 
highest expression levels in the stomach fundus [2]. The 
low expression of this receptor in the brain is unusual 
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since most other serotonin receptors display highest ex- 
pression levels in this organ. The SHT,, receptor which 
is most closely related to the 5-HTZ8 receptor, is found 
almost exclusively in the brain and the choroid plexus 
[lO-121. It may be speculated that these two receptors are 
the central and peripheral counterparts of one another. 
The low level of 5-HT,, receptor RNA found in brain 
tissue may then be attributed to the blood vessels. By 
comparison, the 5-HT,, receptor is expressed in the 
brain and in the periphery [8,35,36]. Additional research 
will show if this distinction of 5-HTZB as a peripheral and 
5-HT,, as a central receptor is valid. 
After expression of the human 5-HTzB receptor in 
HEK 293 cells, agonist-binding stimulates phosphatidy- 
linositol hydrolysis. This had previously also been shown 
for the rat 5-HT,, receptor [2,3]. The pharmacology of 
this response corresponds well with that of the rat 5- 
HT,, receptor determined in membrane binding experi- 
ments and in a similar functional assay [2,3]. The high 
affinity of yohimbine and the low affinity of spiperone 
clearly distinguish the pharmacology of this receptor 
from those of the 5-HT,, and 5-HTzA receptors, respec- 
tively [2]. The efficiency of the serotonin-induced 
phosphatidylinositol hydrolysis is, however, significantly 
weaker in cells expressing the human 5-HTZB than that 
observed in cells expressing other 5-HT, receptor types 
under the same conditions. In cells transiently trans- 
fected with a 5-HT,, receptor clone, for example, the 
serotonin-induced stimulation of phosphatidylinositol 
breakdown is approximately three times stronger than 
that seen in cells transfected with the human 5-HTzB 
receptor clone under the same conditions (data not 
shown). Previously, we demonstrated that the rat homo- 
logue of this receptor displays similar coupling in Xen- 
opus oocytes which is also profoundly weaker than that 
observed with the other 5-HT, receptor types [2]. This 
raises the question, wether the 5-HTZB receptor is able to 
couple to other signalling pathways as well. 
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